• Info
  • Insider Ownership

Insider Trading & Ownership of David A. Cory

Location
Palo Alto, CA
Summary
The estimated net worth of David A. Cory is at least $50,366 dollars as of 11 Mar 2022. David A. Cory is the President and CEO, Director of Eiger BioPharmaceuticals, Inc. and owns shares of Eiger BioPharmaceuticals, Inc. stock worth about $50.4K.
Signature
/s/ Sriram Ryali, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow David A. Cory and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • David A. Cory has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $50,366.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Eiger BioPharmaceuticals, Inc. ($50,366).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of David A. Cory

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EIGR Eiger BioPharmaceuticals, Inc. President and CEO, Director $50,366 11 Mar 2022

Insider Transactions Reported by David A. Cory:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored